Literature DB >> 16613660

Rapid detection of epidermal growth factor receptor mutations in non-small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes.

Caicun Zhou1, Jian Ni, Yinmin Zhao, Bo Su.   

Abstract

UNLABELLED: We investigated somatic mutations of the epidermal growth factor receptor gene in non-small cell lung cancer tumor tissue and their detection using real-time polymerase chain reaction with TaqMan-MGB probes.
METHODS: The DNA was extracted from surgically resected non-small cell lung cancer tumor specimens. Genes encoding for epidermal growth factor receptor tyrosine (exons 18, 19, and 21) were amplified by nested polymerase chain reaction, sequenced, and analyzed by chromatograms with manual review. TaqMan-MGB probes were designed to detect the epidermal growth factor receptor gene mutations in the tumor tissues using real-time polymerase chain reaction.
RESULTS: Somatic point mutations and deletions were identified in the tyrosine kinase domain of the epidermal growth factor receptor gene in 21 of 80 non-small cell lung cancer patients, including 13 patients with deletion mutations occurring in exon 19 and 8 patients with point mutations occurring in codon 858 (exon 21). The results from real-time polymerase chain reaction with TaqMan-MGB probes were completely consistent with sequencing outcomes. Both the sensitivity and specificity for detecting the epidermal growth factor receptor gene mutations using real-time polymerase chain reaction with TaqMan-MGB probes were 100%. The mutation incidence was significantly higher in female patients, nonsmokers, and patients with adenocarcinoma than in male patients, smokers, and those with nonadenocarcinomas (P < 0.05). The mutations were not related to patient's age or tumor nodal metastasis staging.
CONCLUSIONS: Somatic mutations of the epidermal growth factor receptor gene that develop in non-small cell lung cancer patients are more common in female patients, nonsmokers, and patients with adenocarcinoma. Real-time polymerase chain reaction using TaqMan-MGB probes is effective, simple, and fast in the detection of epidermal growth factor receptor gene mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613660     DOI: 10.1097/00130404-200601000-00007

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  13 in total

1.  Meta-analysis of the association of AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms and endometriosis risk in Asians.

Authors:  Neng-neng Zheng; Ya-ping Bi; Ying Zheng; Ruo-heng Zheng
Journal:  J Assist Reprod Genet       Date:  2015-06-23       Impact factor: 3.412

2.  Association of MTHFR gene polymorphisms with pancreatic cancer: meta-analysis of 17 case-control studies.

Authors:  Fangfang Nie; Mingli Yu; Kaili Zhang; Luping Yang; Qian Zhang; Shan Liu; Mengwei Liu; Mengke Shang; Fanxin Zeng; Wanyang Liu
Journal:  Int J Clin Oncol       Date:  2019-11-07       Impact factor: 3.402

3.  The role of molecular pathology in non-small-cell lung carcinoma-now and in the future.

Authors:  G D A Brandao; E F Brega; A Spatz
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

Review 4.  Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: a meta-analysis from 114 studies with 15411 cases and 21970 controls.

Authors:  Boyi Yang; Shujun Fan; Xueyuan Zhi; Yongfang Li; Yuyan Liu; Da Wang; Miao He; Yongyong Hou; Quanmei Zheng; Guifan Sun
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

5.  EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods.

Authors:  Gerald Schmid-Bindert; Yongsheng Wang; Hongbin Jiang; Hui Sun; Thomas Henzler; Hao Wang; Lothar R Pilz; Shengxiang Ren; Caicun Zhou
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

6.  RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies.

Authors:  Jun Liu; Yan-Jun Jia; Xiao-Lin Li; Rui-Xa Xu; Cheng-Gang Zhu; Yuan-Lin Guo; Na-Qiong Wu; Jian-Jun Li
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

7.  A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry.

Authors:  Bárbara Angulo; Esther Conde; Ana Suárez-Gauthier; Carlos Plaza; Rebeca Martínez; Pilar Redondo; Elisa Izquierdo; Belén Rubio-Viqueira; Luis Paz-Ares; Manuel Hidalgo; Fernando López-Ríos
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

8.  Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.

Authors:  Guiyang Jiang; Chuifeng Fan; Xiupeng Zhang; Qianze Dong; Liang Wang; Yang Liu; Shundong Dai; Lianhe Yang; Yong Zhang; Juanhan Yu; Enhua Wang
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

9.  Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

Authors:  Hye-Ryoun Kim; Sung Yong Lee; Dae-Sung Hyun; Min Ki Lee; Hyun-Kyung Lee; Chang-Min Choi; Sei-Hoon Yang; Young-Chul Kim; Yong Chul Lee; Sun Young Kim; Seung Hun Jang; Jae Cheol Lee; Kye Young Lee
Journal:  J Exp Clin Cancer Res       Date:  2013-08-09

10.  Detection of rare point mutation via allele-specific amplification in emulsion PCR.

Authors:  Changming Cheng; Yin Zhou; Chao Yang; Juan Chen; Jie Wang; Jie Zhang; Guoping Zhao
Journal:  BMB Rep       Date:  2013-05       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.